Literature DB >> 15206022

Atypical hemolytic uremic syndrome associated with group A beta hemolytic streptococcus.

Bilal Yildiz, Nurdan Kural, Coskun Yarar.   

Abstract

Entities:  

Mesh：

Year:  2004        PMID： 15206022     DOI： 10.1007/s00467-004-1536-7

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN： 0931-041X            Impact factor:   3.714


× No keyword cloud information.
  10 in total

Review 1.  Death receptors: signaling and modulation.

Authors:  A Ashkenazi; V M Dixit
Journal:  Science       Date:  1998-08-28       Impact factor: 47.728

2.  Invasive pneumococcal disease and hemolytic uremic syndrome.

Authors:  John Brandt; Craig Wong; Susan Mihm; Joan Roberts; Jodi Smith; Eileen Brewer; Ravi Thiagarajan; Bradley Warady
Journal:  Pediatrics       Date:  2002-08       Impact factor: 7.124

3.  Hemolytic uremic syndrome associated with group A beta-hemolytic streptococcus.

Authors:  Amy B Shepherd; April L Palmer; Steven A Bigler; Radhakrishna Baliga
Journal:  Pediatr Nephrol       Date:  2003-06-26       Impact factor: 3.714

4.  Atypical (non-diarrhea-associated) hemolytic-uremic syndrome in childhood.

Authors:  M M Fitzpatrick; M D Walters; R S Trompeter; M J Dillon; T M Barratt
Journal:  J Pediatr       Date:  1993-04       Impact factor: 4.406

5.  Outcome and prognostic determinants in the hemolytic uremic syndrome of children.

Authors:  B Tönshoff; A Sammet; I Sanden; O Mehls; R Waldherr; K Schärer
Journal:  Nephron       Date:  1994       Impact factor: 2.847

Review 6.  Pathogenesis, treatment, and therapeutic trials in hemolytic uremic syndrome.

Authors:  H Trachtman; E Christen
Journal:  Curr Opin Pediatr       Date:  1999-04       Impact factor: 2.856

7.  Thrombin generation and fibrinolysis in the thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome.

Authors:  J Monteagudo; A Pereira; J C Reverter; J Pijoan; J Tusell; L Puig; A Ordinas; R Castillo
Journal:  Thromb Haemost       Date:  1991-11-01       Impact factor: 5.249

8.  Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule.

Authors:  J Cheng; T Zhou; C Liu; J P Shapiro; M J Brauer; M C Kiefer; P J Barr; J D Mountz
Journal:  Science       Date:  1994-03-25       Impact factor: 47.728

9.  Microvascular thrombosis in pediatric multiple organ failure: Is it a therapeutic target?

Authors:  Trung Nguyen; Mark Hall; Yong Han; Melinda Fiedor; Andrea Hasset; Ileana Lopez-Plaza; Scott Watson; Lucy Lum; Joseph A. Carcillo
Journal:  Pediatr Crit Care Med       Date:  2001-07       Impact factor: 3.624

10.  Fibrinolysis in health and disease: abnormal levels of plasminogen activator, plasminogen activator inhibitor, and protein C in thrombotic thrombocytopenic purpura.

Authors:  P Glas-Greenwalt; J M Hall; T W Panke; K S Kant; C M Allen; V E Pollak
Journal:  J Lab Clin Med       Date:  1986-11
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.